Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets

Transfusion

Volumn 52, Issue 6, 2012, Pages 1237-1244

  Ringwald, Juergen ^a,b   Tully, Susanne ^a,b   Geier, Christoph ^a,b   Hauck, Barbara ^a,b   Weiss, Dominik ^a,b   Callaert, Martine ^a,b   Eckstein, Reinhold ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b CaridianBCT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; D DIMER; GLUCOSE; LACTIC ACID; PADGEM PROTEIN; PLATELET ADDITIVE SOLUTION; PRESERVATION SOLUTION; UNCLASSIFIED DRUG;

APHERESIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERCONCENTRATED PLATELET SUSPENSION; IN VITRO STUDY; MALE; NORMAL HUMAN; PH; PLASMA; PROTEIN EXPRESSION; THROMBOCYTE;

BLOOD DONORS; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SHAPE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOTONIC SOLUTIONS; MALE; ORGAN PRESERVATION SOLUTIONS; P-SELECTIN; PLATELET ACTIVATION; PLATELETPHERESIS; QUALITY CONTROL; TIME FACTORS;

EID: 84862257533     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03435.x     Document Type: Article

References (30)

1. Irsch J, Lin L. Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood system. Transfus Med Hemother 2011;38:19-31.
2. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004;44:877-85. (Pubitemid 38738418)
3. Ringwald J, Zimmermann R, Eckstein R. The new generation of platelet additive solution for storage at 22 degrees C: development and current experience. Transfus Med Rev 2006;20:158-64.
4. Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V. Implementation of a strategy to prevent TRALI in a regional blood centre. Transfus Med 2004;14:157-64. (Pubitemid 38623078)
5. Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. How much residual plasma may cause TRALI? Transfus Med 2008;18:276-80.
6. Ringwald J, Duerler T, Frankow O, Zimmermann R, Zingsem J, Strasser E, Antoon M, Eckstein R. Collection of hyperconcentrated platelets with Trima Accel. Vox Sang 2006;90:92-6. (Pubitemid 43381496)
7. Ringwald J, Walz S, Zimmermann R, Zingsem J, Strasser E, Weisbach V, Eckstein R. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality. Vox Sang 2005;89:11-8. (Pubitemid 40839545)
8. Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010;50:2362-75.
9. Ringwald J, Haager B, Krex D, Zimmermann R, Strasser E, Antoon M, De Schrijver E, Eckstein R. Impact of different hold time before addition of platelet additive solution on the in vitro quality of aphersis platelets. Transfusion 2006;46:942-8. (Pubitemid 43800912)
10. Algora-Weber M, Garcia-Sanchez F, Ortega B, Jurado M, Rodriguez MA, Ruiz-Sanchez C, Martinez-Clavel A, Lucas C, Perez S, Garcia L, Barbolla L. Effect of the immediate and delayed platelet storage addition on the platelet activation measured as P-selectin expression [abstract]. Vox Sang 2009;96 Suppl 1:34.
11. German Medical Association and Paul Ehrlich Institute. Guidelines for the collection of blood and blood components and the use of blood products (hemotherapy). Cologne: Deutscher Aerzteverlag; 2010.
12. German Society for Transfusion Medicine and Immunohematology. Performance of preparative cellular hemapheresis for the collection of blood cell concentrates. II. Recommendations for preparative white cell and platelet apheresis. Infusionsther Transfusionsmed 1998;25:376-82.
13. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 16th ed. Strasbourg: Council of Europe Publishing; 2010.
14. Zingsem J, Zimmermann R, Weisbach V, Glaser A, van Waeg G, Eckstein R. Comparison of COBE white cellreduction and standard plateletpheresis protocols in the same donors. Transfusion 1997;37:1045-9. (Pubitemid 27459590)
15. Lutz P, Dzik WH. Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBCreduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration. Transfusion 1993;33:409-12. (Pubitemid 23144024)
16. Moroff G, Eich J, Dabay M. Validation of use of the Nageotte hemocytometer to count low levels of white cells in white cell-reduced platelet components. Transfusion 1994;34:35-8. (Pubitemid 24018763)
17. Zingsem J, Glaser A, Weisbach V, Zimmermann R, Neidhardt B, vanWaeg G, Eckstein R. Evaluation of a platelet apheresis technique for the preparation of leukocyte-reduced platelet concentrates. Vox. Sang 1998;74:189-92. (Pubitemid 28167618)
18. Zingsem J, Weisbach V, Zimmermann R, Glaser A, Bunkens H, Eckstein R. Preparation of fresh frozen plasma as a by-product of plateletapheresis. Transfusion 2002;42:81-6.
19. Hervig T, Mansoor MA, Farstad M. Endogenous glutathione and platelet function in platelet concentrates stored in plasma or platelet additive solution. Transfus Med 2001;11:97-104. (Pubitemid 32455660)
20. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Transfusion 1998;38:31-40. (Pubitemid 28090937)
21. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, Eckstein R. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001;41:1217-24. (Pubitemid 33000956)
22. Ringwald J, Krex D, Weiss D, Hendelmeier M, Zingsem J, Eckstein R. Do platelets stored in additive solution really show limited osmotic balance? Transfusion 2009;49:605-7.
23. Radwanski K, Wagner SJ, Skripchenko A, Min K. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5. Transfusion 2011. [Epub ahead of print].
24. Hirayama J, Azuma H, Fujihara M, Homma C, Yamamoto S, Ikeda H. Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007;47:960-5. (Pubitemid 46802082)
25. Hirayama J, Azuma H, Fujihara M, Akino M, Homma C, Yamamoto S, Kato T, Ikeda H. Storage of platelets in 30 percent plasma and 70 percent M-sol additive solution. Transfusion 2008;48:567-8. (Pubitemid 351294590)
26. Hirayama J, Azuma H, Fujihara M, Akino M, Homma C, Kato T, Ikedo H. Comparison between in vitro qualities of platelets washed with commercially available additive solutions and those washed with M-sol. Vox Sang 2010;99:131-5.
27. Dumont LJ, VandenBroeke T, Ault KA. Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST)Working Party of the International Society of Blood Transfusion (ISBT). Tranfus Med Rev 1999;13:31-42.
28. Curvers J, deWildt-Eggen J, Heeremans J, Scharenberg J, de Korte D, van der Meer PF. Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort. Transfusion 2008;48:1439-46.
29. Wagner SJ, Myrup A, Awatefe H, Thompson-Montgomery D, Hirayama J, Skripchenko A. Maintenance of platelet in vitro properties during 7-day storage in M-sol with 30-hour interruption of agitation. Transfusion 2008;48:2501-607.
30. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996;93:11877-82. (Pubitemid 26347217)